BGIM
SUPN icon

Brandywine Global Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Brandywine Global Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-226,345
Closed -$6.6M – 744
2021
Q4 		$6.6M Hold
226,345
– – 0.05% 350
2021
Q3 		$6.04M Sell
226,345
-18,088
-7% -$485K 0.05% 356
2021
Q2 		$7.53M Sell
244,433
-8,556
-3% -$262K 0.06% 332
2021
Q1 		$6.62M Sell
252,989
-12,562
-5% -$351K 0.05% 366
2020
Q4 		$6.68M Buy
265,551
+40,948
+18% +$881K 0.06% 326
2020
Q3 		$4.68M Buy
+224,603
New +$5.1M 0.05% 331
2017
Q2 		– Sell
-83,985
Closed -$2.63M – 940
2017
Q1 		$2.63M Sell
83,985
-2,996
-3% -$80.3K 0.02% 543
2016
Q4 		$2.2M Sell
86,981
-26,899
-24% -$601K 0.01% 566
2016
Q3 		$2.82M Sell
113,880
-3,018
-3% -$68.3K 0.02% 524
2016
Q2 		$2.38M Sell
116,898
-28,777
-20% -$510K 0.02% 531
2016
Q1 		$2.22M Sell
145,675
-21,845
-13% -$285K 0.01% 527
2015
Q4 		$2.25M Buy
167,520
+158,680
+1,795% +$2.45M 0.01% 543
2015
Q3 		$125K Buy
8,840
+900
+11% +$16.7K ﹤0.01% 763
2015
Q2 		$135K Buy
+7,940
New +$113K ﹤0.01% 773

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brandywine Global Investment Management's SUPN Position: Q1 2022 in Review

Brandywine Global Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2022, closing a stake of 226,345 shares — an estimated $6.6M sold.

Brandywine Global Investment Management first reported a position in SUPN in Q2 2015 and held it in 14 quarters. The position peaked at $7.53M in Q2 2021. 230 funds tracked by Wall St. Rank hold SUPN as of Q1 2022.

  • Brandywine Global Investment Management reported no remaining Supernus Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Brandywine Global Investment Management sold 226,345 Supernus Pharmaceuticals shares in Q1 2022, an estimated $6.6M.
  • Brandywine Global Investment Management first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 14 quarters.
  • Brandywine Global Investment Management's Supernus Pharmaceuticals position peaked at $7.53M in Q2 2021.
  • 230 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2022.

Based on Brandywine Global Investment Management's 13F filing for Q1 2022, filed 13 May 2022.